Co-investment Plan - Director/PDMRs conditional share awards
Bodycote announces that on 29 May 2014, in accordance with the rules of the
Bodycote Co-Investment Plan ("CIP"), the Company made Matching Share awards
over ordinary shares in the Company ("Ordinary Shares").
The awards noted below comprise a maximum conditional award of Ordinary Shares
of 17 3/11p each subject to the rules of the CIP and the applicable performance
targets. The awards only vest to the extent performance criteria is met in
2017. No payment was made for the grant of awards. Awards were made as follows:
Name PDMR Number of Matching Shares
Awarded
Stephen Harris Chief Executive 8,047
David Landless Finance Director 9,335
Dan McCurdy PDMR 10,468
Peter Selbach PDMR 9,665
Tom Gibbons PDMR 1,398
Paul Clough PDMR 5,249
The total number of ordinary shares in which each of the executive directors*
and other PDMRs below hold a beneficial interest is:
Stephen Harris* Chief Executive 574,295
David Landless* Finance Director 505,493
Dan McCurdy PDMR 248,637
Peter Selbach PDMR 7,202
Tom Gibbons PDMR 812
Paul Clough PDMR 59,100
Contact for queries:
Ute Ball, Company Secretary: Springwood Court, Macclesfield, SK10 2XF
Tel: 01625 505300
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.